Latest Articles
-
Can Intuitive Surgical Stock Trend Higher After Q4 Release?
Intuitive Surgical (NASDAQ:ISRG), a fast growing medical devices company, is scheduled to report its fiscal Q4 2020 results on Thursday, January 21. We expect Intuitive Surgical to likely beat the revenue and earnings expectations, driven by a st...
-
Should You Buy Intuitive Surgical Stock At $775 Levels?
Intuitive Surgical (NASDAQ:ISRG), a fast growing medical devices company, is up 30% since the start of the year and it has gained around over 2x from its March lows. We believe that Intuitive Surgical could offer an upside in the near term, as th...
-
Illumina Looks Like Great Value Compared To Intuitive Surgical Stock
Illumina (NASDAQ: ILMN), best known for its genetic variation and biological function systems, trades at about 12x trailing Revenues, compared to over 19x for Intuitive Surgical (NASDAQ: ISRG), which manufactures robotic surgical platforms. Does ...
-
Intuitive Surgical Stock Headed To $1,000 Levels?
Intuitive Surgical (NASDAQ:ISRG), a fast growing medical devices company with a market capitalization of $84 billion, has seen its stock rise by 20% this year, outperforming the broader indices, with the S&P 500 up 4%. The stock now trades at...
-
Despite An 85% Rally Intuitive Surgical Stock Can Grow Further
Intuitive Surgical’s stock (NASDAQ: ISRG) lost more than 38% – dropping from $600 at the beginning of the year to below $370 in late March – then spiked 85% to around $680 now. That means it is well above the levels where it started the y...
-
Is Stryker A Better Buy Compared To Intuitive Surgical?
Intuitive Surgical’s stock (NASDAQ:ISRG) has rallied 56% since the March 23 lows, while Stryker stock (NYSE:SYK) has gained 41% of its value. The spread of Covid-19 in various parts of the world has had a negative impact on the medical devices in...
-
Is There More Upside For Intuitive Surgical’s Stock After A 50% Rebound?
Intuitive Surgical’s stock (NASDAQ: ISRG) has outperformed with over a 50% gain since the recent lows of March 23, compared to the broader S&P 500, which gained 34%. Looking at other medical device companies, Abbott and Boston Scientifi...
-
Can Intuitive Surgical Fall Below $400?
Despite a 16% decline in Intuitive Surgical’s (NASDAQ:ISRG) stock since the beginning of the year, at the current price of around $500, we believe Intuitive Surgical’s stock hasn’t bottomed out yet. Why is that? The potential downside...
-
50% Drop in Revenue Growth for Intuitive Surgical This Year?
Intuitive Surgical’s (NASDAQ:ISRG) revenue grew 65% from $2.7 billion in 2016 to $4.5 billion in 2019, and it is estimated to be $5.0 billion in 2020. While the revenue grew around 20% in 2018 and 2019, the growth rate is likely to slow 0.6...
-
Ride Intuitive Surgical Over Boston Scientific In The Current Crisis?
Based on historical performance, Intuitive Surgical (NASDAQ:ISRG) appears to be an attractive bet compared to Boston Scientific (NYSE:BSX) in the current crisis. The current coronavirus crisis will likely impact medical devices companies on two f...
-
Can Intuitive Surgical Stock Outperform The Broader S&P 500 After Coronavirus?
Intuitive Surgical (NASDAQ:ISRG) stock has fared better than the broader markets through the current crisis, and it will likely bounce back strongly and potentially outperform the broader markets, when the crisis winds down. For perspective, the...
-
What’s The Upside For Intuitive Surgical’s Stock?
There is an upside of over 6% for Intuitive Surgical’s (NASDAQ:ISRG) stock, in our view. We estimate Intuitive Surgical’s fair price estimate to be around $652, based on expected EPS of $14.59 on an adjusted basis for full year 2020 ...
-
Intuitive Surgical’s Full Year 2019 Earnings Could Be Slightly Below Consensus
Intuitive Surgical’s (NASDAQ:ISRG) is slated to release its Q4 and full-year 2019 results on Thursday, January 23, 2020. For full year 2019, Trefis estimates that the company will likely report: Revenues of $4.3 billion, reflecting 17% y...
-
Why Did R&D Jump 2x In 4 Years for Intuitive Surgical?
Intuitive Surgical’s (NASDAQ:ISRG) research and development (R&D) expenses jumped 2x from $197 million in 2015 to $418 million in 2018, due to its new devices development initiatives, including da Vinci Single Port Surgical System and ...
-
Intuitive Surgical’s Revenue Growth Could Slow?
Intuitive Surgical (NASDAQ:ISRG) generates its revenues primarily from sales of robotic surgical systems, and its related accessories & services. While the revenues have grown at an average annual rate of 15% over the last 5 years, the pace ...
